Detected ·
Dragonfleye Therapeutics
$37.5MOther
Toronto-based Dragonfleye Therapeutics announced US$37.5M across two private placements to advance its retinal treatment technology, including a micro-injector for in-office retinal detachment repair and sustained-release glaucoma implants.
- Website
- —
- —
- Amount
- $37 500 000 USD
- Stage
- Other
- Event
- Funding round
- Detected
- 2026-10-30 00:12:14 UTC
- Signal ID
- 8ee8a55f-aa8b-4a93-b67d-ecc4356335f7
As the API returns it
{
"id": "8ee8a55f-aa8b-4a93-b67d-ecc4356335f7",
"created_at": "2026-10-30T00:12:14.144799Z",
"company_name": "Dragonfleye Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 37500000,
"funding_currency": "USD",
"funding_stage": "other",
"message": "*Toronto-based Dragonfleye Therapeutics announced US$37.5M across two private placements to advance its retinal treatment technology, including a micro-injector for in-office retinal detachment repair and sustained-release glaucoma implants.*"
}